Get the Stockscreener App
79.74
2.26%
1.73
After Hours:
79.74
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $79.74, with a volume of 1.10M.
It is up +2.26% in the last 24 hours and up +3.18% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$78.01
Open:
$77.58
24h Volume:
1.10M
Relative Volume:
0.68
Market Cap:
$38.87B
Revenue:
$10.40B
Net Income/Loss:
$980.00M
P/E Ratio:
40.38
EPS:
1.9749
Net Cash Flow:
$1.61B
1W Performance:
+6.89%
1M Performance:
+3.18%
6M Performance:
+9.88%
1Y Performance:
-10.98%
1-Day Range:
$77.50
$79.86
1-Week Range:
$73.92
$79.86
52-Week Range:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC vs ISRG, BDX, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
79.74 | 38.02B | 10.40B | 980.00M | 1.61B | 1.9749 |
ISRG
Intuitive Surgical Inc
|
458.95 | 160.05B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.37 | 43.87B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
47.22 | 37.01B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
230.20 | 33.34B | 5.40B | 1.49B | 1.78B | 10.12 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-26 | Initiated | William Blair | Mkt Perform |
| Jan-20-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-09-26 | Downgrade | Stifel | Buy → Hold |
| Dec-11-25 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Analysis Recap: Will Alcon Inc benefit from rate cutsEarnings Miss & Weekly High Momentum Picks - baoquankhu1.vn
Alcon Inc stock (CH0432492467): Is its eye care dominance strong enough to unlock new upside? - AD HOC NEWS
Alcon Inc stock (CH0432492467): Is vision care dominance strong enough to unlock new upside? - AD HOC NEWS
Sight Sciences wins $34M patent ruling against Alcon - MSN
Alcon launches Clareon TruPlus monofocal and toric IOL - Eyes On Eyecare
Alcon Inc stock: What you need to know before investing now - AD HOC NEWS
Assessing Alcon (SWX:ALC) Valuation After Clareon TruPlus Lens Launch At ASCRS Meeting - Yahoo Finance
Is It Time To Reconsider Alcon (SWX:ALC) After Its 15.5% One Year Share Price Decline - Yahoo Finance
Mexican Gold Mining Corp. and Alcon Silver Corp. Announce Arrangement Agreement to Create a Diversified Precious Metals Exploration Company - TMX Newsfile
Bridges Investment Fund's Alcon Inc(ALC) Holding History - GuruFocus
Alcon Inc (ALC) Trading 3.96% Higher on Apr 8 - GuruFocus
AB SUSTAINABLE INTERNATIONAL THEMATIC FUND INC's Alcon Inc(XSWX:ALC) Holding History - GuruFocus
Alcon Shares Rise After Introducing Clareon TruPlus at ASCRS - Bitget
Alcon Stock Gains Following the Launch of Clareon TruPlus at ASCRS - Yahoo Finance
Alcon Inc. stock: Why eye health leader stands out for investors now - AD HOC NEWS
U.S. Federal Trade Commission – Proposed Merger Between Alcon, Inc. And Lensar, Inc. Abandoned Following Competition Concerns - marketscreener.com
Former Alcon executive named as chief operating officer at biotech company Nanoscope - Fort Worth Report
Alcon Inc stock: What you should know about its eye care leadership now - AD HOC NEWS
Blue Jays eye-drop deal spotlights dry eye for 8.5 million Canadians - Stock Titan
Alcon Inc stock: What investors should know about its eye care leadership now - AD HOC NEWS
Alcon Announces U.S. Launch of Clareon TruPlus IOLs - VisionMonday.com
Alcon (ALC) Launches Clareon TruPlus Intraocular Lens in the U.S. - GuruFocus
Alcon Rolls Out Clareon TruPlus Intraocular Lens in U.S. - Medical Product Outsourcing
Alcon Inc. (ALC) Stock Price, News, Quote & History - Yahoo Finance
Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026 - Business Wire
Alcon Expands Manufacturing in West Virginia With $81 Million Investment - VisionMonday.com
How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset - Yahoo Finance
Alcon Sets April 30, 2026 AGM, Proposes New Director and CHF 0.28 Dividend - The Globe and Mail
Alcon Inc stock: Steady eye care leader amid market pressures? - AD HOC NEWS
Systane eye drops: Are Alcon’s German bestsellers worth it in the US? - AD HOC NEWS
Nanoscope Therapeutics Names Former Alcon Exec as Its New COO - National Today
Alcon Inc. (ALC) stock price, news, quote and history - Yahoo Finance Singapore
Alcon (NYSE: ALC) plans CHF 0.28 dividend and board votes at 2026 AGM - Stock Titan
Alcon Publishes Agenda for 2026 Annual General Meeting - Business Wire
Nanoscope brings in Alcon veteran as COO ahead of launch phase - The Pharma Letter
Alcon Inc. announces Annual dividend, payable on May 07, 2026 - marketscreener.com
Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and HCA Healthcare (HCA) - theglobeandmail.com
Systane Eye Drops: Alcon's Leading Dry Eye Relief Product Driving Steady Growth in North American Op - AD HOC NEWS
List of 19 Acquisitions by Alcon (Apr 2026) - Tracxn
Lensar outlines 46%–49% gross margin forecast for 2026 as it restarts growth after Alcon deal termination - MSN
Alcon Inc Stock Faces Patent Setback and Merger Termination: Key Implications for NYSE:ALC Investors - AD HOC NEWS
Sight Sciences wins $34M in Alcon patent case, ongoing royalty By Investing.com - Investing.com South Africa
ALC Stock Price, Quote & Chart | ALCON INC (NYSE:ALC) - ChartMill
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):